CPT code 90865 denotes the administration of a narcotic drug to induce a hypnotic state for psychiatric diagnosis and treatment. The procedure supports diagnostic clarification or therapeutic response assessment by producing a controlled, drug-induced hypnotic state under clinical supervision. Nationally, this code is relevant for psychiatric programs that employ pharmacologically induced hypnosis as part of complex diagnostic or treatment protocols, and it has implications for facility capability, credentialing, and payer coverage policies.

Key payers referenced in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context and typical sites of care where 90865 is performed, an outline of what elements constitute the service, and guidance on what to expect from payer coverage patterns and policy documentation. The publication covers common billing considerations, typical claim pathways, and areas where policy updates or clarifications are often needed. Data not available in the input is noted in relevant sections. The material is intended to inform billing staff, clinical coders, and policy analysts about the clinical role and administrative handling of CPT code 90865 at a national level.